Jazz Pharmaceuticals PLC <JAZZ.O>: Canaccord Genuity initiates coverage with Buy rating; target price $290
JAZZ•Related News
Nasdaq trade halt continues <UCFIW.O> reason not available at 08:04 pm
UCFIW•
NASDAQ Trade Halt <PFSA.O> Halt News Pending at 07:50 PM
PFSA•
Essent’s SVP, Chief Risk Officer Vijay Bhasin sells 483 common shares for $33,810
ESNT•
Q2 CFO Jonathan Price sells 77,180 shares for $5.07 million
QTWO•
Nasdaq trade halt continues <UCFIW.O> reason not available at 03:28 AM
UCFIW•